LFSC
F/m Emerald Life Sciences Innovation ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$33.61
-0.21 ▼ -0.62%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$33.61
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -2.63% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -6.52% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -14.58% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.36 | Perf Half Y | 16.5% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.00M | Perf YTD | -8.21% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -16.19% ($40.10) | Perf Year | 48.6% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 78.97% ($18.78) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 1.56% 1.71% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.79 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 32.12 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -5.83% ($35.69) | Beta | 1.45 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -6.42% ($35.92) | Rel Volume | 1.73 | Prev Close | $33.82 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 8.54% ($30.97) | Avg Volume(3M) | 0.01M | Price | $33.61 |
| IPO | 2024/10/31 | Option/Short | No/Yes | Trades | 47 | Volume | 11,299 | Change | -0.62% |
뉴스 로딩 중...